Propanc Biopharma (PPCB) EPS (Basic) (2020 - 2025)
Propanc Biopharma (PPCB) posted quarterly EPS (Basic) of -$7.53 for Q4 2025, up 99.07% year-over-year from -$3.78 in Q4 2024, and up 23.23% quarter-over-quarter from -$9.81 in Q3 2025.
Propanc Biopharma (PPCB) EPS (Basic) (2020 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported EPS (Basic) for 6 consecutive years, with -$7.53 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) rose 99.07% year-over-year to -$7.53; the TTM figure through Dec 2025 stood at -$125.37 (up 96.03% YoY), while the FY2025 annual figure was -$371.22, up 98.75% from the prior year.
- EPS (Basic) advanced to -$7.53 in Q4 2025 per PPCB's latest filing, from -$9.81 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$7.53 in Q4 2025 and bottomed at -$805760.0 in Q2 2023.
- Historically, EPS (Basic) has averaged -$86242.0 across 5 years, with a median of -$8287.6 in 2024.
- Annual changes were most pronounced in 2023 — EPS (Basic) plunged 4856.88% — and 2025, when it soared 99.51%.
- Propanc Biopharma's EPS (Basic) stood at -$22907.1 in 2021, then jumped by 97.13% to -$657.21 in 2022, then slumped by 4856.88% to -$32577.3 in 2023, then surged by 97.53% to -$805.59 in 2024, then surged by 99.07% to -$7.53 in 2025.
- Business Quant data shows PPCB's EPS (Basic) at -$7.53 in Q4 2025, -$9.81 in Q3 2025, and -$25.65 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | -7.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.53 |
| Sep 30, 2025 | -9.81 |
| Jun 30, 2025 | -25.65 |
| Mar 31, 2025 | -312.46 |
| Dec 31, 2024 | -805.59 |
| Sep 30, 2024 | -749.07 |
| Jun 30, 2024 | -5,273.21 |
| Mar 31, 2024 | -11,302.08 |
| Dec 31, 2023 | -32,577.32 |
| Sep 30, 2023 | -54,826.78 |
| Jun 30, 2023 | -805,760.00 |
| Mar 31, 2023 | -526.19 |
| Dec 31, 2022 | -657.21 |
| Sep 30, 2022 | -2,655.75 |
| Jun 30, 2022 | -21,081.35 |
| Mar 31, 2022 | -13,208.98 |
| Dec 31, 2021 | -22,907.05 |
| Sep 30, 2021 | -27,522.82 |
| Jun 30, 2021 | -585,385.00 |
| Mar 31, 2021 | -139,246.00 |